LinkedIn Profile

Access Stentys historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal GICS Sector GICS Industry
private:stentys 583279 Mar 30th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 30th, 2020 06:58PM Mar 30th, 2020 06:58PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 29th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 29th, 2020 07:06PM Mar 29th, 2020 07:06PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 28th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 28th, 2020 07:19PM Mar 28th, 2020 07:19PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 27th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 27th, 2020 07:25PM Mar 27th, 2020 07:25PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 26th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 26th, 2020 06:34PM Mar 26th, 2020 06:34PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 25th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 25th, 2020 04:53PM Mar 25th, 2020 04:53PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 24th, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 24th, 2020 01:32PM Mar 24th, 2020 01:32PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 23rd, 2020 12:00AM STENTYS 2.9K 34.00 Open Medical Device Mar 23rd, 2020 06:27PM Mar 23rd, 2020 06:27PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 22nd, 2020 12:00AM STENTYS 2.9K 35.00 Open Medical Device Mar 21st, 2020 09:39PM Mar 22nd, 2020 07:18PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services
private:stentys 583279 Mar 20th, 2020 12:00AM STENTYS 2.8K 35.00 Open Medical Device Mar 20th, 2020 01:41PM Mar 20th, 2020 01:41PM STENTYS is developing and commercializing innovative solutions for the treatment of patients with complex artery disease. STENTYS’ SelfApposing® drug-eluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters in order to prevent the malapposition problems associated with conventional stents. The APPOSITION clinical trials in the treatment of acute myocardial infarction showed a very low one year mortality rate and a faster arterial healing compared to conventional stents. The company’s product portfolio also includes MiStent SES®, a coronary DES whose new drug delivery mechanism is designed to match vessel response, and is marketed through STENTYS’ commercial network in Europe, the Middle East, Asia and Latin America. Open stent, coronary artery disease, AMI, ACS, Bifurcation, Nitinol, Self-Apposing stent, Self-expanding stent, DES, BMS, Aspiration catheter Open 18, Rue d'hauteville Paris Ile-de-France FR 75010 Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.